Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Bio-Path Holdings, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 434.2K | 450.2K | +16.0K (+3.7%) |
| Value | $2.23M | $1.70M | −$530.0K (−23.8%) |
New holders (3)
Institutions that held Bio-Path Holdings, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bailard, Inc. | 33,521 | $126.0K | 0.00% |
| Captrust Financial Advisors | 250 | $1.00K | 0.00% |
| Aquire Wealth Advisors, LLC | 3 | $0 | 0.00% |
Sold out (3)
Institutions that held Bio-Path Holdings, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Citadel Advisors LLC | 12,404 | $64.0K |
| Tower Research Capital LLC (TRC) | 1,405 | $7.00K |
| Ironwood Financial, llc | 82 | $0 |